Order Article Reprints

Bruyère CLdl, Souquet P-J, Dalle S, Corbaux P, Boespflug A, Duruisseaux M, Kiakouama-Maleka L, Reverdy T, Maugeais M, Sahin G, et al. Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes. Cancers. 2021; 13(10):2365. https://doi.org/10.3390/cancers13102365

Bruyère, Charline Lafayolle de la, Pierre-Jean Souquet, Stéphane Dalle, Pauline Corbaux, Amélie Boespflug, Michaël Duruisseaux, Lize Kiakouama-Maleka, Thibaut Reverdy, Madeleine Maugeais, Gulsum Sahin, and et al. 2021. "Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes" Cancers 13, no. 10: 2365. https://doi.org/10.3390/cancers13102365

Bruyère, C. L. d. l., Souquet, P.-J., Dalle, S., Corbaux, P., Boespflug, A., Duruisseaux, M., Kiakouama-Maleka, L., Reverdy, T., Maugeais, M., Sahin, G., Maillet, D., & Péron, J. (2021). Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes. Cancers, 13(10), 2365. https://doi.org/10.3390/cancers13102365